Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Rochester Medical Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Rochester Medical Center brings 13 presentations to ASH 2026 in New Orleans. Its research centres on red cell production, bone marrow niches and acute myeloid leukemia. It includes a safety run-in of an all-oral combination for IDH2-mutated AML.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
University of Rochester's academic medical center, including Strong Memorial Hospital and the Wilmot Cancer Institute.
Talk
Sun Dec 13
4:30pm–5:45pm
The Interplay Between Pyrimidine Synthesis and Ferroptosis in Erythropoiesis
How nucleotide building interacts with an iron-driven cell death from damaged membrane fats, a major cause of failed red cell production in beta-thalassemia.
Red cells · Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Rochester Medical Center

Tell us what you sell and we’ll find the people at University of Rochester Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction